Advertisement
Advertisement
Dalacin C

Dalacin C

clindamycin

Manufacturer:

Pfizer

Distributor:

Zuellig
Concise Prescribing Info
Contents
Clindamycin (cap: HCl; granules for oral soln: palmitate HCl; inj: phosphate)
Indications/Uses
Upper resp infections including tonsillitis, pharyngitis, sinusitis, otitis media & scarlet fever. Lower resp infections including bronchitis, pneumonia, empyema & lung abscess. Skin & soft tissue infections including acne, furuncles, cellulitis, impetigo, abscesses, & wound infections; erysipelas & paronychia (panaritium). Bone & joint infections including osteomyelitis & septic arthritis. Gynecological infections including endometritis, cellulitis, vag cuff infection & tubo-ovarian abscess, salpingitis & pelvic inflammatory disease when given in conjunction w/ an antibiotic of appropriate gm -ve aerobic spectrum; cervicitis due to Chlamydia trachomatis. Intra-abdominal infections including peritonitis & abdominal abscess when given in conjunction w/ an antibiotic of appropriate gm -ve aerobic spectrum. Septicemia & endocarditis. Dental infections eg, periodontal abscess & periodontitis. In combination w/ pyrimethamine for toxoplasmic encephalitis in AIDS patients if intolerant to conventional treatment. In combination w/ primaquine for Pneumocystis jiroveci pneumonia in AIDS patients if intolerant to or do not respond adequately to conventional treatment. In combination w/ quinine for malaria, including multi-resistant Plasmodium falciparium. Prophylaxis of endocarditis in patients sensitive/allergic to penicillin(s); infection in neck & head surgery. Inj: Intraoperative irrigant of the surgical field when diluted in normal saline. In concomitant use w/ aminoglycosides (eg, gentamicin or tobramycin) in prevention of peritonitis or intra-abdominal abscess after bowel perforation & bacterial contamination secondary to trauma.
Dosage/Direction for Use
Cap Adult 600-1,800 mg/day divided in 2, 3 or 4 equal doses. Childn >1 mth who can swallow cap 8-25 mg/kg/day in 3 or 4 equal doses. Granules for oral soln Childn >1 mth 8-25 mg/kg/day in 3 or 4 equal doses. Childn ≤10 kg Min recommended dose: 37.5 mg tid. Inj Adult 2,400-2,700 mg IM/IV given in 2, 3, or 4 equal doses for intra-abdominal area, female pelvis, & other complicated or serious infections. 1,200-1,800 mg IM/IV daily in 3 or 4 equal doses for less complicated infections due to more susceptible microorganisms. Childn >1 mth 20-40 mg/kg/day in 3 or 4 equal doses. Neonate <1 mth 15-20 mg/kg/day in 3 or 4 equal doses. β-hemolytic streptococcal infection Follow previously mentioned dosage recommendation for adult, childn, & neonate. Continue treatment for at least 10 days. Pelvic inflammatory disease 900 mg IV every 8 hr daily + antibiotic IV w/ an appropriate gm -ve aerobic spectrum. Continue IV for at least 4 days & at least 48 hr after improvement, then continue w/ oral dose 450-600 mg every 6 hr daily to complete 10-14 days total therapy. Chlamydia trachomatis cervicitis Cap 450-600 mg qid for 10-14 days. Toxoplasmic encephalitis in AIDS patient Cap/inj 600-1,200 mg orally or IV every 6 hr for 2 wk followed by 300-600 mg orally every 6 hr. Usual total duration: 8-10 wk. Pyrimethamine dose: 25-75 mg orally each day for 8-10 wk. Folinic acid dose: 10-20 mg/day w/ higher doses of pyrimethamine. Pneumocystis carinii pneumonia in AIDS patient Cap 300-450 mg every 6 hr & primaquine 15-30 mg once daily for 21 days. Inj 600-900 mg IV every 6 hr or 900 mg IV every 8 hr & primaquine 15-30 mg orally once daily for 21 days. Acute streptococcal tonsillitis/pharyngitis Cap 300 mg bid for 10 days. Uncomplicated malaria/P. falciparum Cap/granules for oral soln Adult Quinine sulfate 650 mg tid for 3 or 7 days + clindamycin 20 mg base/kg/day divided tid for 7 days. Childn Quinine sulfate 10 mg/kg tid for 3 or 7 days + clindamycin 20 mg base/kg/day divided tid for 7 days. Severe malaria Cap/granules for oral soln Adult Quinidine gluconate 10 mg/kg loading dose IV over 1-2 hr, then 0.02 mg/kg/min continuous infusion for at least 24 hr. Once parasite density <1% & patient can take oral medication, complete treatment w/ oral quinine, same dosing regimen as uncomplicated malaria + clindamycin 20 mg base/kg/day divided tid for 7 days. If patient is not able to take oral medication, give 10 mg base/kg clindamycin loading dose IV followed by 5 mg base/kg IV every 8 hr. Switch to oral clindamycin as soon as patient can take oral medication. Treatment course: 7 days. Childn Quinidine gluconate same dosing as for adults + clindamycin 20 mg base/kg/day divided tid for 7 days. If patient is not able to take oral medication, give 10 mg base/kg clindamycin loading dose IV followed by 5 mg base/kg IV every 8 hr. Switch to oral clindamycin as soon as patient can take oral medication. Treatment course: 7 days. Prophylaxis of endocarditis in penicillin-sensitive patient Cap/granules for oral soln Adult 600 mg 1 hr before procedure. Childn20 mg/kg 1 hr before procedure. Inj 600 mg IV 1 hr before procedure. Prophylaxis of head & neck surgery infection Inj 900 mg diluted in 1,000 mL normal saline as an intraoperative irrigant prior to wound closure.
Administration
Cap: May be taken with or without food: Swallow whole w/ a full glass of water & in an upright position. Granules for oral soln: Should be taken with food.
Contraindications
Hypersensitivity to clindamycin or lincomycin.
Special Precautions
Discontinue if hypersensitivity or severe skin reactions eg, DRESS, SJS, TEN, & acute generalized exanthematous pustulosis (AGEP) occurs. Reports of pseudomembranous colitis & Clostridioides difficile-associated diarrhea. Not to be used in the treatment of meningitis. Potentially nephrotoxic; reported acute kidney injury including acute renal failure. Consider & perform monitoring of renal function during therapy of patients w/ pre-existing renal dysfunction or taking concomitant nephrotoxic drugs; & if therapy is prolonged. Perform LFTs for prolonged therapy. Pregnancy & lactation. Cap: Risk of esophagitis & esophageal ulcer. Inj: May result in overgrowth of non-susceptible organisms, particularly yeasts. Do not inj IV undiluted as a bolus. Risk of gasping syndrome in premature & low birth wt infants due to benzyl alcohol content.
Adverse Reactions
Pseudomembranous colitis, Clostridioides difficile colitis, vag infection; agranulocytosis, neutropenia, thrombocytopenia, leukopenia, eosinophilia; anaphylactic shock & reaction, anaphylactoid reaction, hypersensitivity; dysgeusia; cardio-resp arrest; hypotension; diarrhea, abdominal pain, vomiting, nausea; jaundice; TEN, SJS, DRESS, AGEP, angioedema, exfoliative dermatitis, bullous dermatitis, maculopapular rash, urticaria, erythema multiforme, pruritus, morbilliform rash; acute kidney injury; abnormal LFT. Cap/granules for oral soln: Esophageal ulcer, esophagitis. Inj: Thrombophlebitis; pain, inj site abscess/irritation.
Drug Interactions
May enhance action of other neuromuscular blocking agents. Reduced clearance w/ CYP3A4 & CYP3A5 inhibitors. Increased clearance w/ CYP3A4 & CYP3A5 inducers. Monitor for loss of effectiveness in the presence of strong CYP3A4 inducers eg, rifampicin.
MIMS Class
Other Antibiotics
ATC Classification
J01FF01 - clindamycin ; Belongs to the class of lincosamides. Used in the systemic treatment of infections.
Presentation/Packing
Form
Dalacin C cap 150 mg
Packing/Price
100's (P6,009.43/pack)
Form
Dalacin C cap 300 mg
Packing/Price
100's (P8,737.56/pack)
Form
Dalacin C granules for oral soln 75 mg/5 mL
Packing/Price
(flavoured) 60 mL x 1's (P437.34/bottle)
Form
Dalacin C inj 150 mg/mL
Packing/Price
4 mL x 1's (P1,398.64/ampoule)
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement